Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carson-Walter, E. B.
Right arrow Articles by St. Croix, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carson-Walter, E. B.
Right arrow Articles by St. Croix, B.
[Cancer Research 61, 6649-6655, September 15, 2001]
© 2001 American Association for Cancer Research

Advances in Brief

Cell Surface Tumor Endothelial Markers Are Conserved in Mice and Humans1

Eleanor B. Carson-Walter, D. Neil Watkins, Akash Nanda, Bert Vogelstein, Kenneth W. Kinzler2 and Brad St. Croix2

The Howard Hughes Medical Institute [E. B. C-W., B. V.] and The Johns Hopkins Oncology Center [D. N. W., A. N., K. W. K., B. S. C.], Baltimore, Maryland 21231

We recently identified genes encoding tumor endothelial markers (TEMs) that displayed elevated expression during tumor angiogenesis. From both biological and clinical points of view, TEMs associated with the cell surface membrane are of particular interest. Accordingly, we have further characterized four such genes, TEM1, TEM5, TEM7, and TEM8, all of which contain putative transmembrane domains. TEM5 appears to be a seven-pass transmembrane receptor, whereas TEM1, TEM7, and TEM8 span the membrane once. We identified mouse counterparts of each of these genes, designated mTEM1, mTEM5, mTEM7, and mTEM8. Examination of these mTEMs in mouse tumors, embryos, and adult tissues demonstrated that three of them (mTEM1, mTEM5, and mTEM8) were abundantly expressed in tumor vessels as well as in the vasculature of the developing embryo. Importantly, expression of these mTEMs in normal adult mouse tissues was either undetectable or detected only in a small fraction of the vessels. These results demonstrate conservation of human and mouse tumor angiogenesis at the molecular level and support the idea that tumor angiogenesis largely reflects normal physiological neovasculaturization. The coordinate expression of TEM1, TEM5, and TEM8 on tumor endothelium in humans and mice makes these genes attractive targets for the development of antiangiogenic therapies.




This article has been cited by other articles:


Home page
 IOVSHome page
Y. Yamaji, S. Yoshida, K. Ishikawa, A. Sengoku, K. Sato, A. Yoshida, R. Kuwahara, K. Ohuchida, E. Oki, H. Enaida, et al.
TEM7 (PLXDC1) in Neovascular Endothelial Cells of Fibrovascular Membranes from Patients with Proliferative Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3151 - 3157.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
H.-F. Duan, X.-W. Hu, J.-L. Chen, L.-H. Gao, Y.-Y. Xi, Y. Lu, J.-F. Li, S.-R. Zhao, J.-J. Xu, H.-P. Chen, et al.
Antitumor Activities of TEM8-Fc: An Engineered Antibody-like Molecule Targeting Tumor Endothelial Marker 8
J Natl Cancer Inst, October 17, 2007; 99(20): 1551 - 1555.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
H. Klement, B. St. Croix, C. Milsom, L. May, Q. Guo, J. L. Yu, P. Klement, and J. Rak
Atherosclerosis and Vascular Aging as Modifiers of Tumor Progression, Angiogenesis, and Responsiveness to Therapy
Am. J. Pathol., October 1, 2007; 171(4): 1342 - 1351.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Su, J. Ortiz, S. Liu, T. H. Bugge, R. Singh, S. H. Leppla, and A. E. Frankel
Systematic Urokinase-Activated Anthrax Toxin Therapy Produces Regressions of Subcutaneous Human Non-Small Cell Lung Tumor in Athymic Nude Mice
Cancer Res., April 1, 2007; 67(7): 3329 - 3336.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K.-H. Chen, S. Liu, L. A. Bankston, R. C. Liddington, and S. H. Leppla
Selection of Anthrax Toxin Protective Antigen Variants That Discriminate between the Cellular Receptors TEM8 and CMG2 and Achieve Targeting of Tumor Cells
J. Biol. Chem., March 30, 2007; 282(13): 9834 - 9845.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. J. Buckanovich, D. Sasaroli, A. O'Brien-Jenkins, J. Botbyl, R. Hammond, D. Katsaros, R. Sandaltzopoulos, L. A. Liotta, P. A. Gimotty, and G. Coukos
Tumor Vascular Proteins As Biomarkers in Ovarian Cancer
J. Clin. Oncol., March 1, 2007; 25(7): 852 - 861.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Vallon and M. Essler
Proteolytically Processed Soluble Tumor Endothelial Marker (TEM) 5 Mediates Endothelial Cell Survival during Angiogenesis by Linking Integrin {alpha}vbeta3 to Glycosaminoglycans
J. Biol. Chem., November 10, 2006; 281(45): 34179 - 34188.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. L. Zarling, J. M. Polefrone, A. M. Evans, L. M. Mikesh, J. Shabanowitz, S. T. Lewis, V. H. Engelhard, and D. F. Hunt
From the Cover: Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy
PNAS, October 3, 2006; 103(40): 14889 - 14894.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Guo, J. Li, H. Wang, M. Osato, J. P. Tang, S. Y. Quah, B. Q. Gan, and Q. Zeng
PRL-3 Initiates Tumor Angiogenesis by Recruiting Endothelial Cells In vitro and In vivo
Cancer Res., October 1, 2006; 66(19): 9625 - 9635.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
X.-Y. Chen, W. Zhang, W. Zhang, S. Wu, F. Bi, Y.-J. Su, X.-Y. Tan, J.-N. Liu, and J. Zhang
Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.
Clin. Cancer Res., October 1, 2006; 12(19): 5834 - 5840.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
J. L. Jadrich, M. B. O'Connor, and E. Coucouvanis
The TGF{beta} activated kinase TAK1 regulates vascular development in vivo.
Development, April 1, 2006; 133(8): 1529 - 1541.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Nanda, B. Karim, Z. Peng, G. Liu, W. Qiu, C. Gan, B. Vogelstein, B. St. Croix, K. W. Kinzler, and D. L. Huso
Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors
PNAS, February 28, 2006; 103(9): 3351 - 3356.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
I. Maeda, T. Takano, H. Yoshida, F. Matsuzuka, N. Amino, and A. Miyauchi
Tensin3 is a novel thyroid-specific gene
J. Mol. Endocrinol., February 1, 2006; 36(1): R1 - R8.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
P. A. Campochiaro and the First ARVO/Pfizer Institute Working Group
Ocular versus Extraocular Neovascularization: Mirror Images or Vague Resemblances
Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 462 - 474.
[Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
B. Rono, J. Romer, S. Liu, T. H. Bugge, S. H. Leppla, and P. E.G. Kristjansen
Antitumor efficacy of a urokinase activation-dependent anthrax toxin
Mol. Cancer Ther., January 1, 2006; 5(1): 89 - 96.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
H. Akiyama, K. A. Mohamedali, R. L. e Silva, S. Kachi, J. Shen, C. Hatara, N. Umeda, S. F. Hackett, S. Aslam, M. Krause, et al.
Vascular Targeting of Ocular Neovascularization with a Vascular Endothelial Growth Factor121/Gelonin Chimeric Protein
Mol. Pharmacol., December 1, 2005; 68(6): 1543 - 1550.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
H. Kim, S R Herrick, E Lemyre, S Kishikawa, J A Salisz, S Seminara, M E MacDonald, G A P Bruns, C C Morton, B J Quade, et al.
Hypogonadotropic hypogonadism and cleft lip and palate caused by a balanced translocation producing haploinsufficiency for FGFR1
J. Med. Genet., August 1, 2005; 42(8): 666 - 672.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
G. Bonuccelli, F. Sotgia, P. G. Frank, T. M. Williams, C. J. de Almeida, H. B. Tanowitz, P. E. Scherer, K. A. Hotchkiss, B. I. Terman, B. Rollman, et al.
ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection
Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1402 - C1410.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Berger, G. Bergers, B. Arnold, G. J. Hammerling, and R. Ganss
Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization
Blood, February 1, 2005; 105(3): 1094 - 1101.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Nanda, P. Buckhaults, S. Seaman, N. Agrawal, P. Boutin, S. Shankara, M. Nacht, B. Teicher, J. Stampfl, S. Singh, et al.
Identification of a Binding Partner for the Endothelial Cell Surface Proteins TEM7 and TEM7R
Cancer Res., December 1, 2004; 64(23): 8507 - 8511.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Hida, Y. Hida, D. N. Amin, A. F. Flint, D. Panigrahy, C. C. Morton, and M. Klagsbrun
Tumor-Associated Endothelial Cells with Cytogenetic Abnormalities
Cancer Res., November 15, 2004; 64(22): 8249 - 8255.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
C. Liu, C. Dickinson, J. Shobe, F. Donate, W. Ruf, and T. Edgington
A hybrid fibronectin motif protein as an integrin targeting selective tumor vascular thrombogen
Mol. Cancer Ther., July 1, 2004; 3(7): 793 - 801.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. B. Lacy, D. J. Wigelsworth, H. M. Scobie, J. A. T. Young, and R. J. Collier
Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: An anthrax toxin receptor
PNAS, April 27, 2004; 101(17): 6367 - 6372.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
Y. Cui, Y.-C. Liao, and S. H. Lo
Epidermal Growth Factor Modulates Tyrosine Phosphorylation of a Novel Tensin Family Member, Tensin3
Mol. Cancer Res., April 1, 2004; 2(4): 225 - 232.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Walter-Yohrling, S. Morgenbesser, C. Rouleau, R. Bagley, M. Callahan, W. Weber, and B. A. Teicher
Murine Endothelial Cell Lines as Models of Tumor Endothelial Cells
Clin. Cancer Res., March 15, 2004; 10(6): 2179 - 2189.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Nanda, E. B. Carson-Walter, S. Seaman, T. D. Barber, J. Stampfl, S. Singh, B. Vogelstein, K. W. Kinzler, and B. St. Croix
TEM8 Interacts with the Cleaved C5 Domain of Collagen {alpha}3(VI)
Cancer Res., February 1, 2004; 64(3): 817 - 820.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Lapointe, C. Li, J. P. Higgins, M. van de Rijn, E. Bair, K. Montgomery, M. Ferrari, L. Egevad, W. Rayford, U. Bergerheim, et al.
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
PNAS, January 20, 2004; 101(3): 811 - 816.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. E. Thorpe
Vascular Targeting Agents as Cancer Therapeutics
Clin. Cancer Res., January 15, 2004; 10(2): 415 - 427.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. J. Favre, M. Mancuso, K. Maas, J. W. McLean, P. Baluk, and D. M. McDonald
Expression of genes involved in vascular development and angiogenesis in endothelial cells of adult lung
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1917 - H1938.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
M. Shen, L. Guo, A. Wallace, J. Fitzner, J. Eisenman, E. Jacobson, and R. S. Johnson
Isolation and Isotope Labeling of Cysteine- and Methionine-containing Tryptic Peptides: Application to the Study of Cell Surface Proteolysis
Mol. Cell. Proteomics, May 1, 2003; 2(5): 315 - 324.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. M. Scobie, G. J. A. Rainey, K. A. Bradley, and J. A. T. Young
Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor
PNAS, April 29, 2003; 100(9): 5170 - 5174.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Liu and S. H. Leppla
Cell Surface Tumor Endothelium Marker 8 Cytoplasmic Tail-independent Anthrax Toxin Binding, Proteolytic Processing, Oligomer Formation, and Internalization
J. Biol. Chem., February 7, 2003; 278(7): 5227 - 5234.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Kawakatsu, K. Shimizu, T. Honda, T. Fukuhara, T. Hoshino, and Y. Takai
trans-Interactions of Nectins Induce Formation of Filopodia and Lamellipodia through the Respective Activation of Cdc42 and Rac Small G Proteins
J. Biol. Chem., December 20, 2002; 277(52): 50749 - 50755.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. N. Johnstone, L. M. Chang, and M. Ernst
AACR Special Meeting in Cancer Research: Colon Cancer--Genetics to Prevention
Cancer Res., November 15, 2002; 62(22): 6779 - 6783.
[Full Text] [PDF]

Home page
 The OncologistHome page
C. J. Conti
Vascular Endothelial Growth Factor: Regulation in the Mouse Skin Carcinogenesis Model and Use in Antiangiogenesis Cancer Therapy
Oncologist, August 1, 2002; 7(90003): 4 - 11.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. J. Bernardi, C. S. Johnson, R. A. Modzelewski, and D. L. Trump
Antiproliferative Effects of 1{alpha},25-Dihydroxyvitamin D3 and Vitamin D Analogs on Tumor-Derived Endothelial Cells
Endocrinology, July 1, 2002; 143(7): 2508 - 2514.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Porkka, P. Laakkonen, J. A. Hoffman, M. Bernasconi, and E. Ruoslahti
A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo
PNAS, May 28, 2002; 99(11): 7444 - 7449.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. T. Rosenbaum
Sugar Creates a Sticky Business: Round Up the Usual Suspects
Am. J. Pathol., May 1, 2002; 160(5): 1547 - 1550.
[Full Text] [PDF]

Home page
 Vet PatholHome page

Vet. Pathol., January 1, 2002; 39(1): 167 - 168.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.